piperazinone derivatives (Kolon)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namepiperazinone derivatives (Kolon)
Drug Alias NameKL-3331
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase inhibitors
TargetsMatrix metalloproteinase
Therapy Area/IndicationsAngiogenesis disorderNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKolon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKolon Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAngiogenesis disorderNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A